Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics.


Journal

NPJ precision oncology
ISSN: 2397-768X
Titre abrégé: NPJ Precis Oncol
Pays: England
ID NLM: 101708166

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 24 02 2023
accepted: 04 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 10 1 2024
Statut: epublish

Résumé

The consensus molecular subtypes (CMS) of colorectal cancer (CRC) is the most widely-used gene expression-based classification and has contributed to a better understanding of disease heterogeneity and prognosis. Nevertheless, CMS intratumoral heterogeneity restricts its clinical application, stressing the necessity of further characterizing the composition and architecture of CRC. Here, we used Spatial Transcriptomics (ST) in combination with single-cell RNA sequencing (scRNA-seq) to decipher the spatially resolved cellular and molecular composition of CRC. In addition to mapping the intratumoral heterogeneity of CMS and their microenvironment, we identified cell communication events in the tumor-stroma interface of CMS2 carcinomas. This includes tumor growth-inhibiting as well as -activating signals, such as the potential regulation of the ETV4 transcriptional activity by DCN or the PLAU-PLAUR ligand-receptor interaction. Our study illustrates the potential of ST to resolve CRC molecular heterogeneity and thereby help advance personalized therapy.

Identifiants

pubmed: 38200223
doi: 10.1038/s41698-023-00488-4
pii: 10.1038/s41698-023-00488-4
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10

Informations de copyright

© 2024. The Author(s).

Références

Biller, L. H. & Schrag, D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325, 669–685 (2021).
pubmed: 33591350 doi: 10.1001/jama.2021.0106
Wang, W. et al. Molecular subtyping of colorectal cancer: recent progress, new challenges and emerging opportunities. Semin. Cancer Biol. 55, 37–52 (2019).
pubmed: 29775690 doi: 10.1016/j.semcancer.2018.05.002
Okita, A. et al. Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. Oncotarget 9, 18698–18711 (2018).
pubmed: 29721154 pmcid: 5922348 doi: 10.18632/oncotarget.24617
Chan, D. K. H. & Buczacki, S. J. A. Tumour heterogeneity and evolutionary dynamics in colorectal cancer. Oncogenesis 10, 1–9 (2021).
doi: 10.1038/s41389-021-00342-x
Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350–1356 (2015).
pubmed: 26457759 pmcid: 4636487 doi: 10.1038/nm.3967
Lee, H.-O. et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet. 52, 594–603 (2020).
pubmed: 32451460 doi: 10.1038/s41588-020-0636-z
Khaliq, A. M. et al. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 23, 1–30 (2022).
Joanito, I. et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat. Genet. 54, 963–975 (2022).
pubmed: 35773407 pmcid: 9279158 doi: 10.1038/s41588-022-01100-4
Cañellas-Socias, A. et al. Metastatic recurrence in colorectal cancer arises from residual EMP1
pubmed: 36352230 doi: 10.1038/s41586-022-05402-9
Chowdhury, S. et al. Implications of intratumor heterogeneity on consensus molecular subtype (CMS) in colorectal cancer. Cancers 13, 4923 (2021).
Andersson, A. et al. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions. Nat. Commun. 12, 1–14 (2021).
doi: 10.1038/s41467-021-26271-2
Berglund, E. et al. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nat. Commun. 9, 1–13 (2018).
doi: 10.1038/s41467-018-04724-5
Hunter, M. V., Moncada, R., Weiss, J. M., Yanai, I. & White, R. M. Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface. Nat. Commun. 12, 1–16 (2021).
doi: 10.1038/s41467-021-26614-z
Wu, Y. et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 12, 134–153 (2022).
pubmed: 34417225 doi: 10.1158/2159-8290.CD-21-0316
Peng, Z., Ye, M., Ding, H., Feng, Z. & Hu, K. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer. J. Transl. Med. 20, 302 (2022).
pubmed: 35794563 pmcid: 9258101 doi: 10.1186/s12967-022-03510-8
Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP fibroblasts and SPP1 macrophages in colorectal cancer. Nat. Commun. 13, 1742 (2022).
pubmed: 35365629 pmcid: 8976074 doi: 10.1038/s41467-022-29366-6
Zhang, R. et al. Spatial transcriptome unveils a discontinuous inflammatory pattern in proficient mismatch repair colorectal adenocarcinoma. Fundam. Res. https://doi.org/10.1016/j.fmre.2022.01.036 (2022).
Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. https://doi.org/10.1038/s41587-021-01139-4 (2022).
Mevizou, R., Sirvent, A. & Roche, S. Control of tyrosine kinase signalling by small adaptors in colorectal cancer. Cancers 11, 669 (2019).
Nunez, S. K. et al. Identification of gene co-expression networks associated with consensus molecular subtype-1 of colorectal cancer. Cancers 13, 5824 (2021).
García-Aranda, M. & Redondo, M. Targeting receptor kinases in colorectal cancer. Cancers 11, 433 (2019).
Rebersek, M. Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision. Radiol. Oncol. 54, 272–277 (2020).
pubmed: 32463385 pmcid: 7409603 doi: 10.2478/raon-2020-0031
Orouji, E. et al. Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer. Gut 71, 938–949 (2022).
pubmed: 34059508 doi: 10.1136/gutjnl-2020-322835
Martin, T. A. et al. NUPR1 and its potential role in cancer and pathological conditions (Review). Int. J. Oncol. 58, 21 (2021).
Shi, X., Young, C. D., Zhou, H. & Wang, X. Transforming growth factor-β signaling in fibrotic diseases and cancer-associated fibroblasts. Biomolecules 10, 1666 (2020).
Lin, Y., Xu, J. & Lan, H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J. Hematol. Oncol. 12, 76 (2019).
pubmed: 31300030 pmcid: 6626377 doi: 10.1186/s13045-019-0760-3
Thanki, K. et al. Consensus molecular subtypes of colorectal cancer and their clinical implications. Int Biol. Biomed. J. 3, 105–111 (2017).
pubmed: 28825047 pmcid: 5557054
Naito, T. et al. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer. Oncol. Rep. 45, 104 (2021).
Ran, H. et al. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. J. Exp. Clin. Cancer Res. 37, 54 (2018).
pubmed: 29530061 pmcid: 5848567 doi: 10.1186/s13046-018-0711-9
Syed, V. TGF-β Signaling in Cancer. J. Cell. Biochem. 117, 1279–1287 (2016).
pubmed: 26774024 doi: 10.1002/jcb.25496
Tanevski, J., Flores, R. O. R., Gabor, A., Schapiro, D. & Saez-Rodriguez, J. Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol. 23, 97 (2022).
pubmed: 35422018 pmcid: 9011939 doi: 10.1186/s13059-022-02663-5
Neill, T., Schaefer, L. & Iozzo, R. V. Decorin: a guardian from the matrix. Am. J. Pathol. 181, 380–387 (2012).
pubmed: 22735579 pmcid: 3409438 doi: 10.1016/j.ajpath.2012.04.029
Deves, C. et al. Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer. Virchows Arch. 458, 421–430 (2011).
pubmed: 21318373 doi: 10.1007/s00428-011-1053-6
Gİrgİn, B., KaradaĞ-Alpaslan, M. & KocabaŞ, F. Oncogenic and tumor suppressor function of MEIS and associated factors. Turk. J. Biol. 44, 328–355 (2020).
pubmed: 33402862 pmcid: 7759197 doi: 10.3906/biy-2006-25
Du, B., Gao, W., Qin, Y., Zhong, J. & Zhang, Z. Study on the role of transcription factor SPI1 in the development of glioma. Chin. Neurosurg. J. 8, 7 (2022).
pubmed: 35361282 pmcid: 8973577 doi: 10.1186/s41016-022-00276-2
Nie, X., Liu, H., Liu, L., Wang, Y.-D. & Chen, W.-D. Emerging Roles of Wnt Ligands in Human Colorectal Cancer. Front. Oncol. 10, 1341 (2020).
pubmed: 32923386 pmcid: 7456893 doi: 10.3389/fonc.2020.01341
Guillermin, O. et al. Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration. EMBO J. 40, e105770 (2021).
pubmed: 33950519 pmcid: 8246259 doi: 10.15252/embj.2020105770
Koch, M. et al. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res. Treat. 128, 337–346 (2011).
pubmed: 20714802 doi: 10.1007/s10549-010-1085-7
Page-McCaw, A., Ewald, A. J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221–233 (2007).
pubmed: 17318226 pmcid: 2760082 doi: 10.1038/nrm2125
Zhang, J., Sud, S., Mizutani, K., Gyetko, M. R. & Pienta, K. J. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model. Neoplasia 13, 23–30 (2011).
pubmed: 21245937 pmcid: 3022425 doi: 10.1593/neo.10728
Liu, M. et al. Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer. J. Clin. Invest. 130, 2081–2096 (2020).
pubmed: 31945018 pmcid: 7108920 doi: 10.1172/JCI131335
Hara, T. & Tanegashima, K. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis. Biomol. Concepts 5, 167–173 (2014).
pubmed: 25372750 doi: 10.1515/bmc-2014-0007
Reszegi, A. et al. The protective role of decorin in hepatic metastasis of colorectal carcinoma. Biomolecules 10, 1199 (2020).
Fontana, E., Eason, K., Cervantes, A., Salazar, R. & Sadanandam, A. Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials. Ann. Oncol. 30, 520–527 (2019).
pubmed: 30796810 pmcid: 6503627 doi: 10.1093/annonc/mdz052
Dunne, P. D. et al. Challenging the cancer molecular stratification dogma: intratumoral heterogeneity undermines consensus molecular subtypes and potential diagnostic value in colorectal cancer. Clin. Cancer Res. 22, 4095–4104 (2016).
pubmed: 27151745 doi: 10.1158/1078-0432.CCR-16-0032
Eide, P. W., Bruun, J., Lothe, R. A. & Sveen, A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci. Rep. 7, 1–8 (2017).
doi: 10.1038/s41598-017-16747-x
Herrera, M. et al. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients. Mol. Cancer 20, 73 (2021).
pubmed: 33926453 pmcid: 8082938 doi: 10.1186/s12943-021-01367-x
Zhong, Z. A., Michalski, M. N., Stevens, P. D., Sall, E. A. & Williams, B. O. Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer. J. Biol. Chem. 296, 100782 (2021).
pubmed: 34000297 pmcid: 8214085 doi: 10.1016/j.jbc.2021.100782
Tsukiyama, T. et al. Molecular role of RNF43 in canonical and noncanonical Wnt signaling. Mol. Cell. Biol. 35, 2007–2023 (2015).
pubmed: 25825523 pmcid: 4420922 doi: 10.1128/MCB.00159-15
Thasler, W. E. et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank. 4, 49–56 (2003).
pubmed: 15256870 doi: 10.1023/A:1026392429112
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 1–7 (2017).
doi: 10.1038/s41598-017-17204-5
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
pubmed: 29409532 pmcid: 5802054 doi: 10.1186/s13059-017-1382-0
Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137–145 (2020).
pubmed: 31792435 doi: 10.1038/s41592-019-0654-x
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
pubmed: 31870423 pmcid: 6927181 doi: 10.1186/s13059-019-1874-1
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018).
pubmed: 29295995 pmcid: 5750219 doi: 10.1038/s41467-017-02391-6
Alvarez, M. J. et al. Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat. Genet. 48, 838–847 (2016).
pubmed: 27322546 pmcid: 5040167 doi: 10.1038/ng.3593
Garcia-Alonso, L., Holland, C. H., Ibrahim, M. M., Turei, D. & Saez-Rodriguez, J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 29, 1363–1375 (2019).
pubmed: 31340985 pmcid: 6673718 doi: 10.1101/gr.240663.118
Gonzalez, I., Déjean, S., Martin, P. & Baccini, A. CCA: AnRPackage to extend canonical correlation analysis. J. Stat. Softw. 23, 1–14 (2008).
McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 1179–1186 (2017).
pubmed: 28088763 pmcid: 5408845 doi: 10.1093/bioinformatics/btw777
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308 doi: 10.1093/bioinformatics/btp616
Zhao, E. et al. Spatial transcriptomics at subspot resolution with BayesSpace. Nat. Biotechnol. https://doi.org/10.1038/s41587-021-00935-2 (2021)
Lun, A. T. L., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res. 5, 2122 (2016).
pubmed: 27909575 pmcid: 5112579
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
Türei, D. et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol. Syst. Biol. 17, e9923 (2021).
pubmed: 33749993 pmcid: 7983032 doi: 10.15252/msb.20209923
Dimitrov, D. et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat. Commun. 13, 1–13 (2022).
doi: 10.1038/s41467-022-30755-0
Kolde, R., Laur, S., Adler, P. & Vilo, J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28, 573–580 (2012).
pubmed: 22247279 pmcid: 3278763 doi: 10.1093/bioinformatics/btr709
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Chen, B. et al. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Cell 184, 6262–6280.e26 (2021).
pubmed: 34910928 pmcid: 8941949 doi: 10.1016/j.cell.2021.11.031
Kosinski, C. et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl Acad. Sci. USA. 104, 15418–15423 (2007).
pubmed: 17881565 pmcid: 2000506 doi: 10.1073/pnas.0707210104
Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47, D900–D908 (2019).
pubmed: 30329142 doi: 10.1093/nar/gky939
Seo, M.-K., Kang, H. & Kim, S. Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis. Sci. Rep. 12, 6283 (2022).
pubmed: 35428835 pmcid: 9012745 doi: 10.1038/s41598-022-10182-3

Auteurs

Alberto Valdeolivas (A)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. alberto.valdeolivas_urbelz@roche.com.

Bettina Amberg (B)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Nicolas Giroud (N)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Marion Richardson (M)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Eric J C Gálvez (EJC)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Solveig Badillo (S)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Alice Julien-Laferrière (A)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Demeter Túrós (D)

Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Lena Voith von Voithenberg (L)

Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.

Isabelle Wells (I)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Benedek Pesti (B)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Amy A Lo (AA)

Genentech, Inc, San Francisco, CA, USA.

Emilio Yángüez (E)

Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.

Meghna Das Thakur (M)

Genentech, Inc, San Francisco, CA, USA.

Michael Bscheider (M)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Marc Sultan (M)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Nadine Kumpesa (N)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Björn Jacobsen (B)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Tobias Bergauer (T)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Julio Saez-Rodriguez (J)

Faculty of Medicine and Heidelberg University Hospital, Institute of Computational Biomedicine, Heidelberg University, Heidelberg, Germany.

Sven Rottenberg (S)

Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Bern Center for Precision Medicine (BCPM), University of Bern, Bern, Switzerland.

Petra C Schwalie (PC)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Kerstin Hahn (K)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. kerstin.hahn@roche.com.

Classifications MeSH